Michael Burke

As Marathon’s Chief Commercial Officer, Mr. Burke drives the company’s development and commercial strategy. Most recently, he led an investor group that partnered with SureGene’s scientific team to expand the organization and begin commercialization of SureGene’s genetic discoveries.

• Mr. Burke was one of the first members at Ovation Pharmaceuticals’ executive team, where he focused on sales, marketing, business development and the assessment of acquisition targets. In 2008, Michael was named one of the 45 under 45 Emerging Pharma Leaders by Pharmaceutical Executive.
• He became Chief Commercial Officer of Lundbeck Inc. following Lundbeck’s acquisition of Ovation.
• Prior to Ovation, Mr. Burke spent eight years in the Pharmaceuticals Products Division at Abbott Laboratories, where he served in various sales and marketing roles and managed specialty market and primary care product lines.
• He received his BA from Providence College and his MBA from the Kellogg School of Management at Northwestern University.